Majzner_Lab

Robbie Majzner's Lab at Dana Farber. Focus on CAR T cell signaling & engineering, cancer immunotherapy & ganglioside biology. Interested in curing kids!

[Majzner_Lab @Majzner_Lab]

Thank you @psscra @PershingSqFdn @BillAckman @SohnConf for the support of our work to engineer more effective immunotherapies for children and adults with cancer!

[Pershing Square Sohn Cancer Research Alliance @psscra]

We are thrilled to announce the 13 winners of the 2026 Pershing Square Sohn Cancer Prize. Doubling our commitment, this year's scientists have been selected for their bold ideas and potential to transform cancer research. Please join us in congratulating: https://t.co/GGxnNmBiv3

[Majzner_Lab @Majzner_Lab]

@Papa_Heme Give them CAR T cells :)

[Oded Rechavi @OdedRechavi]

It’s published. That’s all that matters

[The Mark Foundation for Cancer Research @TheMarkFdn]

Mariella Filbin (@FilbinMariella) is exploring how aggressive childhood brain tumors hijack normal brain activity to repair their own DNA. This research aims to break through radiation resistance in diffuse midline gliomas. 🧠 @DanaFarberNews

[Majzner_Lab @Majzner_Lab]

Congrats to Kevin Lu from the lab on receiving this great award from @chadtough and the Violet Foundation for Pediatric Cancer! We really appreciate the support and the dedication to help children with DIPG!

[ChadTough Defeat DIPG Foundation @chadtough]

Fellowship Grant awarded to Kevin Lu of Dana-Farber Cancer Institute, mentored by Robbie Majzner and Mariella Filbin.

(co-funded by the Violet Foundation for Pediatric Brain Cancer)

@Majzner_Lab @FilbinMariella

[ChadTough Defeat DIPG Foundation @chadtough]

Fellowship Grant awarded to Kevin Lu of Dana-Farber Cancer Institute, mentored by Robbie Majzner and Mariella Filbin.

(co-funded by the Violet Foundation for Pediatric Brain Cancer)

@Majzner_Lab @FilbinMariella

[Majzner_Lab @Majzner_Lab]

Really excited for the news today as Link Cell Therapies officially launches out of stealth with the announcement of their Series A. The company has been hard at work for several years turning a prototype Boolean-logic AND-gated CAR T cell into a real product with real potential to help patients. With LNK001 headed towards a Phase 1 trial in renal cell carcinoma in 2026, we are excited about the team Link has built - and we hope their work will redefine the universe of antigens and cancers we can target with CAR T cells. Very fortunate to have received backing from @samsaracapital, @JNJInnovation, @bmsnews, @KyowaKirin_US, @Wing_VC, Sheatree Capital, Sherpa Healthcare Partners, & others. https://t.co/KYm3mcc3T0

[Majzner_Lab @Majzner_Lab]

Thanks Ansu for the vote of confidence first in the lab and now with the funding! Really happy to have Wing's backing!

[Ansu Satpathy @Satpathology]

Excited to support Link Cell Therapies' $60M Series A as they emerge from stealth and to partner with an outstanding syndicate led by @JNJInnovation, with participation from @samsaracapital, Sheatree Capital, @bmsnews Bristol Myers Squibb, @KyowaKirin_US, Sherpa Healthcare Partners, and other strategic investors.

I first encountered Link’s groundbreaking technology when it was just a twinkle in founder @Majzner_Lab's eye at Stanford—and @Wing_VC is thrilled to support Link's pioneering work as they take this discovery to the clinic. High-fidelity AND-gated CAR-T therapies will unlock ex vivo and in vivo CAR-T efficacy for solid tumors, and the company's first lead program LNK001 aims to deliver a precise, dual-antigen approach that tackles the persistent on-target/off-tumor toxicity challenge in renal cell carcinoma (RCC).

Congratulations to Robbie and co-founder Crystal Mackall, and to the entire Link Cell Therapies team! Looking forward to watching this transformative technology progress and bring hope to patients battling cancer.

[Wing VC @Wing_VC]

Congratulations to the Link Cell Therapies team on their $60 million Series A! 🚀
https://t.co/fhddIBvlxH

[Chabad Lubavitch HQ @Lubavitch]

STATEMENT BY CHABAD-LUBAVITCH WORLD HEADQUARTERS

We are devastated and heartbroken by the barbaric terror attack against a public Chanukah celebration in Sydney, Australia, on the first night of Chanukah.

We grieve for the families whose loved ones were murdered, among them Chabad emissary Rabbi Elie Schlanger, who led the Chanukah celebration with the people of Bondi Beach. Rabbi Schlanger devoted his life to sharing Jewish warmth, faith, and community with others. He was doing exactly what he had been sent to do—bringing light and joy into the public square—when his life was cut down. Rabbi Schlanger leaves his wife, Chayale and their children, including a two-month old baby. We mourn him as family and stand with his loved ones and his community in their immeasurable loss. May his memory be for a blessing.

We pray that G-d grant healing and comfort to all who survived this attack—men, women, and children—and strength to the families and community now living with its aftermath.

Let us be clear: this was a treacherous act of terror—an attack on community, on goodness, and on light itself. It reflects a climate in which Jew-hatred has been allowed to grow and to turn violent. That reality must be confronted.

This moment demands accountability. Jewish life must be safeguarded through concrete, heightened measures to deter and rein in calls for violence against Jews. We call on governments and law-enforcement authorities to take responsibility, to strengthen security around Jewish institutions and public gatherings, particularly during Chanukah, when Jewish life is expressed openly and visibly.

The Jewish response to terror has never been retreat. Chanukah teaches us to bring light precisely where darkness seeks to intrude. In our times, the Lubavitcher Rebbe, Rabbi Menachem Mendel Schneerson, of blessed memory, insisted that Chanukah lights be placed openly in public spaces as a statement of dignity, faith, and confidence. In that spirit, Chabad-Lubavitch emissaries around the world will continue to light public menorahs—responsibly, in coordination with security authorities, and without surrendering visibility or pride. Jewish life will not be driven from the public square.

We will honor the lives taken by enhancing Jewish practice, pride and visibility. May their light rise from this sorrow, and their memory be a blessing to us all.

Rabbi Yehuda Krinsky
Chairman

[Majzner_Lab @Majzner_Lab]

@drjgauthier Anakinra definitely gets into the CNS. It's recombinant IL1Ra so pretty small (cytokine sized, smaller than IL-6). It's detectable by ELISA/Luminex for IL1Ra. We found it at ~10% of systemic levels in brain tumor pts treated with CAR T. https://t.co/QuQrkJUzkn

[Majzner_Lab @Majzner_Lab]

and importantly thanks to our funders including @CancerGrand @TheMarkFdn @CR_UK @NIH @CancerResearch @parkerici @AACR @ASTCT @AICF_nyc @StanfordMCHRI and to our awesome illustrator @TeamSciStories

[Majzner_Lab @Majzner_Lab]

Congrats to @mcrotiroti on her recent paper published in Nature Cancer now with an accompanying Research Briefing published today: https://t.co/8oxXLaijLU... Mari utilized insights into T cell proximal signaling to overcome antigen-low escape. I have been overdue to write a 🧵!

[Majzner_Lab @Majzner_Lab]

Thanks to many collaborators on this paper which began while we were at @StanfordMed and was completed @DanaFarber - @Satpathology @CalebLareau @KlebanoffLab @Korbinian_NK @leowanglab @AntigoniMDPhD and to all our wonderful lab members